CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands		Mar. 31, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents		$ 1,021,754	$ 1,040,039
Restricted cash and equivalents	[1]	14,470	14,781
Receivables, net		571,869	293,407
Prepaid expenses and other current assets, net		19,847	18,968
Total current assets		1,627,940	1,367,195
Property and equipment, net		12,526	9,161
Intangible assets, net		53,709	55,398
Goodwill		41,540	41,540
Other assets, net		119,496	112,958
Total assets		1,855,211	1,586,252
Current liabilities:
Medical claims and related payables		472,323	239,014
Accounts payable and accrued expenses		133,138	112,946
Current portion of long-term debt		5,000	5,000
Total current liabilities		610,461	356,960
Long-term debt, net of current portion		42,172	43,401
Other liabilities		91,101	94,295
Total liabilities		743,734	494,656
Commitments and contingencies
Stockholders' equity (deficit):
Common stock, $0.01 par value: 2,000,000 shares authorized; 405,727 and 400,095 shares issued and outstanding, respectively		4,057	4,001
Additional paid-in capital		2,064,242	2,045,572
Accumulated deficit		(956,447)	(957,677)
Total agilon health, inc. stockholders' equity (deficit)		1,111,852	1,091,896
Noncontrolling interests		(375)	(300)
Total stockholders’ equity (deficit)		1,111,477	1,091,596
Total liabilities and stockholders' equity (deficit)		$ 1,855,211	$ 1,586,252

[1] Restricted cash and equivalents primarily consist of amounts used as collateral to secure letters of credit that the Company is required to maintain pursuant to contracts with payors.